🇺🇸 Abatacept Injection in United States

9 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Glare — 1 report (11.11%)
  2. Ocular Hyperaemia — 1 report (11.11%)
  3. Physical Product Label Issue — 1 report (11.11%)
  4. Product Storage Error — 1 report (11.11%)
  5. Product Substitution Issue — 1 report (11.11%)
  6. Product Use Complaint — 1 report (11.11%)
  7. Vision Blurred — 1 report (11.11%)
  8. Visual Impairment — 1 report (11.11%)
  9. Wrong Technique In Product Usage Process — 1 report (11.11%)

Source database →

Abatacept Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Abatacept Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Abatacept Injection in United States?

University of Erlangen-Nürnberg Medical School is the originator. The local marketing authorisation holder may differ — check the official source linked above.